Ensign Peak Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $337K | Hold |
29,140
| – | – | ﹤0.01% | 1637 |
|
|
2025
Q1 | $254K | Hold |
29,140
| – | – | ﹤0.01% | 1663 |
|
|
2024
Q4 | $418K | Hold |
29,140
| – | – | ﹤0.01% | 1643 |
|
|
2024
Q3 | $658K | Hold |
29,140
| – | – | ﹤0.01% | 1531 |
|
|
2024
Q2 | $567K | Sell |
29,140
-22,453
| -44% | -$437K | ﹤0.01% | 1568 |
|
|
2024
Q1 | $1.94M | Buy |
51,593
+14,716
| +40% | +$552K | ﹤0.01% | 944 |
|
|
2023
Q4 | $2.06M | Buy |
36,877
+148
| +0.4% | +$8.28K | ﹤0.01% | 902 |
|
|
2023
Q3 | $1.52M | Sell |
36,729
-18,028
| -33% | -$744K | ﹤0.01% | 934 |
|
|
2023
Q2 | $3.06M | Buy |
54,757
+21,129
| +63% | +$1.18M | 0.01% | 735 |
|
|
2023
Q1 | $1.88M | Sell |
33,628
-42,389
| -56% | -$2.36M | ﹤0.01% | 874 |
|
|
2022
Q4 | $2.77M | Buy |
76,017
+51,740
| +213% | +$1.89M | 0.01% | 716 |
|
|
2022
Q3 | $692K | Sell |
24,277
-19,677
| -45% | -$561K | ﹤0.01% | 1278 |
|
|
2022
Q2 | $1.99M | Buy |
43,954
+6,535
| +17% | +$296K | ﹤0.01% | 805 |
|
|
2022
Q1 | $2.85M | Sell |
37,419
-18,681
| -33% | -$1.42M | 0.01% | 752 |
|
|
2021
Q4 | $8.36M | Buy |
56,100
+18,800
| +50% | +$2.8M | 0.02% | 514 |
|
|
2021
Q3 | $5.43M | Sell |
37,300
-23,080
| -38% | -$3.36M | 0.01% | 626 |
|
|
2021
Q2 | $11.8M | Buy |
60,380
+6,766
| +13% | +$1.32M | 0.02% | 398 |
|
|
2021
Q1 | $9.71M | Sell |
53,614
-16,345
| -23% | -$2.96M | 0.02% | 425 |
|
|
2020
Q4 | $9.91M | Sell |
69,959
-20,961
| -23% | -$2.97M | 0.02% | 420 |
|
|
2020
Q3 | $11.3M | Buy |
90,920
+39,334
| +76% | +$4.9M | 0.03% | 421 |
|
|
2020
Q2 | $4.61M | Sell |
51,586
-8,886
| -15% | -$794K | 0.01% | 630 |
|
|
2020
Q1 | $3.77M | Buy |
60,472
+18,047
| +43% | +$1.12M | 0.01% | 597 |
|
|
2019
Q4 | $3.24M | Buy |
+42,425
| New | +$3.24M | 0.01% | 810 |
|